Kamada - High Quality Pharmaceuticals
    Portuguese
  Homepage   About us   Products   Capabilities   Clinical Development   Partners   Investor Relations   News & Events   Contact us  
 
Respiratory
Intravenous AAT
(Alpha-1 Antitrypsin)
Aerosolized AAT **
(Alpha-1 Antitrypsin)
Aerosolized AAT **
(Alpha-1 Antitrypsin)
Aerosolized AAT **
(Alpha-1 Antitrypsin)
 
Immunoglobulins
KamRAB
(Human rabies immunoglobulin/HRIG)
KamRho-D IM
(Human Anti-D (Rho) immunoglobulin
KamRho-D IV
(Human Anti-D (Rho) immunoglobulin)
IVIG*
(IgG immunoglobulins)
 
Critical care
Protosol
(Aprotinin)
Heparin sodium injection*
Heparin Lock Flush
Kamacaine 0.5%
Albumin*
Snake Antiserum**
 
Coagulation Factors
Factor IX*
Factor VIII, VWF*
 
Additional Specialty Proteins
Human Transferrin
    Human Transferrin

  Contact us about Transferrin

Indications
For in vitro and diagnostic use
For pharmaceutical use**

Characteristics
Lyophilized Powder
Liquid – 5% solution

Status
Tissue culture grade - marketed worldwide
Pharmaceutical grade – under development
The company has received a US patent No.7,285, 646 B2 for "Ultra Pure Transferrin for Pharmaceutical Compositions"

Profile
Human Transferrin (HTr) is a blood protein transporting iron to and from body cells. To date, HTr has been available as a plasma-derived product for diagnostic assays and cell cultures, but not for therapeutic uses. Research suggests that HTr may be utilized as a targeting agent for cancer and infectious disease treatments and thus has the potential to render these treatments more effective and less destructive to healthy cells. Kamada is in the initial R&D stages of adapting HTr to allow its use as part of other manufacturers’ medications for the transfer of chemotherapeutic agents to cancerous cells.


** Under Development
    More

Human Transferrin Brochure
 
All rights reserved to Kamada © 2010 Terms and Conditions | Privacy Policy | Colours